Catalyst Wire Dossier Catalyst Wire Dossier

Jaktinib hydrochloride tablets

Jaktinib hydrochloride · Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Jaktinib hydrochloride tablets, covering 2022-11-29 to 2024-12-12. Get the full timeline:

Most recent: Clinical Trial Update: Study of Jaktinib Hydrochloride Tablets in Participants With Idiopathic Pulmonary Fibrosis [Phase 2]

See pricing